Active ingredientBortezomibCat. No. P-B099-001CAS 179324-69-7Family · Pharmaceutical analytical standards
Bortezomib
The first proteasome inhibitor drug, blocking the system that disposes of proteins inside cells: approved in the United States in 2003 for multiple myeloma, it is also used in mantle cell lymphoma. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, other impurities and synthesis intermediates.
Did you know?It was the first boronic acid drug ever approved: it is the boron atom itself that latches onto the active site of the proteasome and blocks it.
Go to the active ingredient →Active ingredientBortezomibCat. No. P-B099-001CAS 179324-69-7
Pharmacopoeial impurityBortezomib Amide AnalogCat. No. P-B099-002CAS 289472-80-6
Isotopically labelledBortezomib-d15Cat. No. P-B099-003
Pharmacopoeial impurity(1R,2R)-BortezomibCat. No. P-B099-004CAS 1132709-15-9
Impurity(1S,2R)-BortezomibCat. No. P-B099-005CAS 1132709-16-0
Impurity(1S,2S)-BortezomibCat. No. P-B099-006CAS 1132709-14-8
Impurity(R)-(1-amino-3-methylbutyl)boronic acid hydrochlorideCat. No. P-B099-007CAS 1158974-93-6
Impurity1-bromo-2-methylpropaneCat. No. P-B099-008CAS 78-77-3
Impurity1-chloro-2-methylpropaneCat. No. P-B099-009CAS 513-36-0
Impurity2-(1H-Imidazole-1-carbonyl)pyrazineCat. No. P-B099-010CAS 103435-88-7
Impurity3,6-Dibenzyl-2,5-dioxopiperazineCat. No. P-B099-011CAS 2308-61-4
ImpurityBoc-D-phenylalanineCat. No. P-B099-012CAS 18942-49-9
ImpurityBortezomib 1-hydroxy Impurity (racemic mixture)Cat. No. P-B099-013
ImpurityBortezomib D-Mannitol EsterCat. No. P-B099-014CAS 444576-08-3
ImpurityBortezomib Hydroxy ImpurityCat. No. P-B099-015
ImpurityBortezomib Hydroxy Ketone AnalogCat. No. P-B099-016CAS 2379402-85-2
ImpurityBortezomib Impurity 1Cat. No. P-B099-017CAS 2747958-64-9
ImpurityBortezomib Impurity 2 (R,S-Isomer)Cat. No. P-B099-019
ImpurityBortezomib Impurity 3 (S,S-Isomer)Cat. No. P-B099-020
ImpurityBortezomib Impurity 4Cat. No. P-B099-021CAS 862895-00-9
ImpurityBortezomib Impurity 5 HydrochlorideCat. No. P-B099-022CAS 1259300-03-2
ImpurityBortezomib Impurity 6Cat. No. P-B099-023
ImpurityBortezomib Impurity 7Cat. No. P-B099-024
ImpurityBortezomib Impurity 8Cat. No. P-B099-025
ImpurityBortezomib Impurity 9Cat. No. P-B099-026
ImpurityBortezomib Impurity 10 (RR-Isomer)Cat. No. P-B099-027
ImpurityBortezomib Impurity 11 (S,R-Isomer)Cat. No. P-B099-028CAS 289472-78-2
ImpurityBortezomib Impurity 12Cat. No. P-B099-029
ImpurityBortezomib Impurity 13Cat. No. P-B099-030
ImpurityBortezomib Impurity 14 TrifluoroacetateCat. No. P-B099-031
ImpurityBortezomib Impurity 15Cat. No. P-B099-032CAS 1569265-85-5
ImpurityBortezomib Impurity 16Cat. No. P-B099-033
ImpurityBortezomib Impurity 17 TrifluoroacetateCat. No. P-B099-034
ImpurityBortezomib Impurity 18Cat. No. P-B099-035
ImpurityBortezomib Impurity 19 Trifluoroacetate HydrateCat. No. P-B099-036CAS 1310383-72-2
ImpurityBortezomib Impurity 20Cat. No. P-B099-038
ImpurityBortezomib Impurity 21Cat. No. P-B099-039
ImpurityBortezomib Impurity 22 HydrochlorideCat. No. P-B099-040CAS 945606-99-5
ImpurityBortezomib Impurity 23 TrifluoroacetateCat. No. P-B099-041CAS 477254-69-6
ImpurityBortezomib Impurity 24Cat. No. P-B099-042
ImpurityBortezomib Impurity 25Cat. No. P-B099-043
ImpurityBortezomib Impurity 26Cat. No. P-B099-044CAS 862894-96-0
ImpurityBortezomib Impurity 27Cat. No. P-B099-046
ImpurityBortezomib Impurity 28 HydrochlorideCat. No. P-B099-047
ImpurityBortezomib Impurity 29Cat. No. P-B099-048CAS 289472-81-7
ImpurityBortezomib Impurity 30Cat. No. P-B099-049CAS 87249-60-3
ImpurityBortezomib Impurity 31Cat. No. P-B099-050CAS 87304-47-0
ImpurityBortezomib Impurity 32Cat. No. P-B099-051CAS 1187479-72-6
ImpurityBortezomib Impurity 33Cat. No. P-B099-054CAS 1194235-28-3
ImpurityBortezomib Impurity 35Cat. No. P-B099-057CAS 2210228-73-0
ImpurityBortezomib Impurity 36Cat. No. P-B099-061CAS 1255646-95-7
ImpurityBortezomib Impurity 37Cat. No. P-B099-062
ImpurityBortezomib Impurity 38Cat. No. P-B099-065CAS 84110-39-4
ImpurityBortezomib Impurity 39Cat. No. P-B099-066CAS 85167-14-2
ImpurityBortezomib Impurity 40Cat. No. P-B099-067CAS 514820-48-5
ImpurityBortezomib Impurity 41Cat. No. P-B099-068CAS 847644-46-6
ImpurityBortezomib Impurity 42Cat. No. P-B099-069
ImpurityBortezomib Impurity 43Cat. No. P-B099-070CAS 179324-86-8
Pharmacopoeial impurityBortezomib L-Phenylalanyl AnalogCat. No. P-B099-075CAS 1194235-41-0
ImpurityDesisobutyl-n-butyl Bortezomib (Mixture of Isomers)Cat. No. P-B099-076
ImpurityDesisobutyl-n-butyl Bortezomib TrimerCat. No. P-B099-077
ImpurityBortezomib N-formyl analogCat. No. P-B099-080
ImpurityBortezomib R-HydroperoxideCat. No. P-B099-081CAS 886979-78-8
ImpurityBortezomib S-HydroperoxideCat. No. P-B099-082CAS 886979-81-3
ImpurityBortezomib Stereo Isomers MixtureCat. No. P-B099-083
ImpurityBortezomib TrimerCat. No. P-B099-084CAS 390800-88-1
ImpurityBortezomib-pinanediolCat. No. P-B099-086CAS 205393-22-2
ImpurityDesisobutyl-n-butyl BortezomibCat. No. P-B099-087CAS 1104011-35-9
ImpurityIsobutylboronic acidCat. No. P-B099-088CAS 84110-40-7
ImpurityL-Phenylalanyl-L-phenylalanineCat. No. P-B099-089CAS 2577-40-4
ImpurityN-Pyrazinylcarbonyl-L-phenylalanine Methyl EsterCat. No. P-B099-090CAS 73058-37-4
ImpurityN-(2-Pyrazinylcarbonyl)-D-phenylalanineCat. No. P-B099-091CAS 1608986-16-8
ImpurityBortezomib Impurity 45Cat. No. P-B099-092CAS 1194235-14-7
ImpurityBortezomib Impurity 46Cat. No. P-B099-093CAS 139442-44-7
ImpurityDes-pyrazinecarboxaldehyde BortezomibCat. No. P-B099-094CAS 948294-96-0
ImpurityDes(boric acid) BortezomibCat. No. P-B099-095CAS 1446194-56-4
Pharmacopoeial impurityN-Pyrazinylcarbonyl-L-phenylalanineCat. No. P-B099-096CAS 114457-94-2
ImpurityPyrazine-2,3-dicarboxylic acidCat. No. P-B099-097CAS 89-01-0
ImpurityBortezomib Impurity 47Cat. No. P-B099-098CAS 7364-51-4
IntermediateBortezomib Intermediate II HydrochlorideCat. No. P-B099-099CAS 205393-21-1
IntermediateBortezomib Intermediate(S,R)Cat. No. P-B099-100CAS 84110-34-9No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.